Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations

AW Asgar, MJ Mack, GW Stone - Journal of the American College of …, 2015 - jacc.org
The development of secondary mitral regurgitation (MR) due to left ventricular dysfunction,
also known as functional MR, is strongly associated with a poor prognosis in patients with …

The evolution from surgery to percutaneous mitral valve interventions: the role of the edge-to-edge technique

F Maisano, G La Canna, A Colombo, O Alfieri - Journal of the American …, 2011 - jacc.org
The edge-to-edge technique is a versatile procedure for mitral valve repair. Its technical
simplicity has been the prerequisite for the development of a number of transcatheter …

Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort

T Feldman, S Kar, M Rinaldi, P Fail, J Hermiller… - Journal of the American …, 2009 - jacc.org
Objectives: We undertook a prospective multicenter single-arm study to evaluate the
feasibility, safety, and efficacy of the MitraClip system (Evalve Inc., Menlo Park, California) …

Beating heart catheter-based edge-to-edge mitral valve procedure in a porcine model: efficacy and healing response

JI Fann, FG St. Goar, J Komtebedde, MC Oz, PC Block… - Circulation, 2004 - Am Heart Assoc
Background—Surgical edge-to-edge repair has been used in the treatment of mitral
regurgitation. We evaluated the ability of a catheter-delivered clip (Evalve, Inc) to achieve …

Mitral repair with the Evalve MitraClip device: histopathologic findings in the porcine model

A Luk, J Butany, E Ahn, JI Fann, FS Goar… - Cardiovascular …, 2009 - Elsevier
INTRODUCTION: Percutaneous mitral repair with the MitraClip device (“clip”) is currently
being evaluated in a Phase II clinical trial (EVEREST II). This device was evaluated in an …

Percutanenous therapies for mitral regurgitation

A Perlowski, FS Goar, DG Glower, T Feldman - Current Problems in …, 2012 - Elsevier
Percutaneous therapies for the treatment of mitral regurgitation have emerged rapidly over
the past several years. Most of the percutaneous approaches are modifications of existing …

[HTML][HTML] Utility of multidetector computed tomographic angiography as an alternative to transesophageal echocardiogram for preoperative transcatheter mitral valve …

C Basman, C Ong, T Kansara, Z Kassam… - Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Three-dimensional (3D) transesophageal echocardiogram (TEE) is the gold
standard for the diagnosis of degenerative mitral regurgitation (dMR) and preoperative …

Mitral regurgitation in the high-risk patient: integrating an Expanding Armamentarium of Transcatheter devices into the treatment algorithm

C Basman, J Johnson, L Pirelli, NC Patel… - Cardiology in …, 2022 - journals.lww.com
Over the last decade, multiple transcatheter mitral valve repair and replacement strategies
have emerged, yet there is only 1 US Food and Drug Administration approved device, the …

Emerging approaches of transcatheter valve repair/insertion

M Taramasso, M Cioni, A Giacomini… - Cardiology …, 2010 - Wiley Online Library
Aortic stenosis (AS) and mitral regurgitation (MR) account for the majority of valvular
diseases and their prevalence is increasing according to increased life expectancy. Surgical …

Optimizing procedural outcomes in percutaneous mitral valve therapy using transesophageal imaging: a stepwise analysis

L Slipczuk, RJ Siegel, H Jilaihawi… - Expert Review of …, 2012 - Taylor & Francis
Moderate or severe mitral regurgitation is the most common valve disease in the USA.
Without treatment, severe mitral regurgitation has a 5-year survival rate of approximately …